- Home
- CPRX vs BHC Comparison
CPRX vs BHC Comparison
Compare CPRX & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CPRX | BHC |
|---|---|---|
| Founded | 2002 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.5B |
| IPO Year | 2006 | N/A |
Fundamental Metrics
Financial Performance| Metric | CPRX | BHC |
|---|---|---|
| Price | $24.17 | $6.81 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 3 |
| Target Price | ★ $32.60 | $8.67 |
| AVG Volume (30 Days) | 1.2M | ★ 2.8M |
| Earning Date | 11-05-2025 | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 44.94 | N/A |
| EPS | ★ 1.71 | 0.97 |
| Revenue | $578,196,000.00 | ★ $10,029,000,000.00 |
| Revenue This Year | $19.87 | $6.81 |
| Revenue Next Year | $7.21 | $4.11 |
| P/E Ratio | $13.83 | ★ $7.15 |
| Revenue Growth | ★ 25.56 | 5.86 |
| 52 Week Low | $19.05 | $4.25 |
| 52 Week High | $26.58 | $8.69 |
Technical Indicators
Market Signals| Indicator | CPRX | BHC |
|---|---|---|
| Relative Strength Index (RSI) | 66.20 | 53.36 |
| Support Level | $22.67 | $6.66 |
| Resistance Level | $23.84 | $7.20 |
| Average True Range (ATR) | 0.68 | 0.31 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 70.80 | 49.30 |
Price Performance
Historical ComparisonAbout CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).
About BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.